DAC HYP compositions and methods

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9340619
SERIAL NO

14671653

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ABBVIE BIOTHERAPEUTICS INCREDWOOD CITY CA 94063

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Burky, John E Newark, US 8 25
Hartman, Taymar E Redwood City, US 11 34
Huang, Ping Y Fremont, US 10 42
Partridge, Braeden D Sunnyvale, US 6 23
Robinson, Thomas J San Mateo, US 7 25
Sauer, Paul W Fremont, US 8 25
Tso, J Yun Menlo Park, US 70 1606
Wesson, Mark C San Ramon, US 7 25

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 17, 2023
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 17, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00